Sulfonamides are a group of antibiotics used to treat or prevent a wide range of infections, including skin, eye, and ear ...

Teva’s asthma and COPD patents listed in the FDA’s Orange Book are under scrutiny and the company has until 24 July to adhere ...

American Regent announces the launch and availability of Sodium Phosphates Injection, USP, which is FDA-approved and therapeutically equivalent to Sodium Phosphates.1 Sodium Phosphates Injection, USP ...

Innovator companies should expect Orange Book patent listing challenges to emerge as an additional and simpler tool for ...

According to "The Washington Post", the FTC claims that drug companies, among them Teva, made slight changes to their ...

The investigation has been prompted by Teva’s refusal to take down about two dozen patents for its asthma and chronic obstructive pulmonary disorder (COPD) inhalers, according to a Washington Post ...

[1] The warning letters sent to the pharmaceutical companies are part of the FTC’s new policy regarding listing of patents in the FDA’s “Approved Drug Products with Therapeutic Equivalence Evaluations ...

Diclofenac is a generic drug prescribed for conditions including arthritis in adults. It’s available as the brand-name drugs Zipsor, Cambia, and others. The cost of diclofenac with and without ...

For context, the Orange Book refers to the “Approved Drug Products with Therapeutic Equivalence Evaluations” publication put out by the U.S. Food and Drug Administration (“FDA”). The aim of the Orange ...

The Company offers a portfolio of products and services ... or as generic finished dosages with therapeutic equivalence to branded formulations (generics). Teva Pharmaceutical Industries Ltd is a ...

which lists approved drug products with therapeutic equivalence evaluations. In related developments, Evofem reported significant growth in net sales for Phexxi in 2023, reaching $18.2 million ...

A London council chief earning nearly £190,000 a year has been charged with drug and driving offences after allegedly failing to stop at the scene of an accident. Bayo Dosunmu, chief executive of ...